子宫内膜浆液性癌诊治的中国专家共识(2022年版)  

Chinese expert consensus on the diagnosis and treatment of uterine serous carcinoma(2022 Edition)

作　　者：中国医师协会微无创医学专业委员会妇科肿瘤学组 中国医院协会妇产医院分会妇科肿瘤专业学组 中国优生科学协会肿瘤生殖学分会 贺红英 方双 袁航 范江涛 王玉东[8] 王建东[9] 张师前[10] 孙阳 王莉[12] 蔡红兵[13] Gynecologic Oncology Group of Minimally Noninvasive Medical Professional Committee of Chinese Medical Doctor Association;Gynecologic Oncology Specialty Group of Obstetrics and Gynecology Hospital Branch of Chinese Hospital Association;Cancer Reproduction Branch of China Healthy Birth Science Association

机构地区：[1]不详 [2]广西医科大学附属柳铁中心医院 [3]广西壮族自治区卫生健康委员会重点培育实验室 [4]柳州市医学分子诊断重点实验室 [5]广西医科大学第四附属医院 [6]山东省妇幼保健院 [7]广西医科大学第一附属医院 [8]上海交通大学医学院附属国际和平妇幼保健院 [9]首都医科大学附属北京妇产医院 [10]山东大学齐鲁医院 [11]福建省肿瘤医院 [12]河南省肿瘤医院 [13]武汉大学中南医院

出　　处：《癌症进展》2022年第9期865-874,879,共11页Oncology Progress

摘　　要：子宫内膜浆液性癌(USC)是非雌激素依赖型子宫内膜癌,具有高度侵袭性,确诊时多为晚期,复发率高,预后不良。基于USC的临床特征、病理特征、分子生物学的特殊性,中国医师协会微无创医学专业委员会妇科肿瘤学组、中国医院协会妇产医院分会妇科肿瘤专业学组、中国优生科学协会肿瘤生殖学分会联合制定本共识,旨在规范和提高USC的诊治水平。Uterine serous carcinoma(USC)is an estrogen-independent endometrial carcinoma,which is highly ag-gressive and is mostly diagnosed at the advanced stage with high recurrence rate and poor prognosis.Based on the clini-cal and pathological characteristics,and the particularity of molecular biology of USC,the Gynecologic Oncology Group of Minimally Noninvasive Medical Professional Committee of Chinese Medical Doctor Association,Gynecologic Oncol-ogy Specialty Group of Obstetrics and Gynecology Hospital Branch of Chinese Hospital Association,Cancer Reproduc-tion Branch of China Healthy Birth Science Association jointly formulated this consensus to standardize and improve the diagnosis and treatment of USC.

关 键 词：子宫内膜癌 子宫内膜浆液性癌 诊断 治疗 专家共识 

分 类 号：R737.33[医药卫生—肿瘤]